Trans fatty acids in human nutrition

• Autorzy: Kuhnt K , Jahreis G.

Warianty tytułu

PL

Kwasy tluszczowe trans w zywieniu czlowieka

• Języki publikacji: EN

Abstrakty

EN

This review comprises the impact of trans fatty acids (tFA) and conjugated linoleic acids (CLA) in the human nutrition. The knowledge of the impact of the relation between dietary tFA and the risk of cardiovascular diseases diabetes mellitus type-2, and cancer increased in the last years. There is increasing evidence that the effects of tFA on human health differ among positional trans-isomers. CLA show various metabolic properties mainly anti-cancerogenic, anti-inflammatory, and antiatherogenic, with potent impact in humans.

Słowa kluczowe

EN

human disease; trans fatty acid; trans configuration; conjugated linoleic acid; structure; lipid; trans isomer; cis configuration; human nutrition; fatty acid; vaccenic acid; atherosclerosis

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2007
• Tom: 34
• Numer: 1-2
• Opis fizyczny: p.46-54,fig.,ref.

Twórcy

autor

Kuhnt K

• Friedrich Schiller University, Jena, Germany

autor

Jahreis G.

Bibliografia

• 1. Albers R., van der Wielen R.P., Brink E.J. et al.: Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur. J. Clin. Nutr. 2003, 57, 595.
• 2. Allison D.B., Egan S.K., Barraj L.M. et al.: Estimated intakes of trans fatty and other fatty acids in the US population. J. Am. Diet. Assoc. 1999, 99, 166.
• 3. Aro A., Mannisto S., Salminen I. et al: Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr. Cancer 2000, 38, 151.
• 4. Ascherio A., Katan M.B., Stampfer M.J. et al.: Trans fatty acids and coronary heart disease. N. Engl. J. Med. 1999, 340, 1994.
• 5. Bassaganya-Riera J., Pogranichniy R.M., Jobgen S.C. et al.: Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. J. Nutr. 2003, 133, 3204.
• 6. Baylin A., Kabagambe E.K., Ascherio A. et al.: High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J. Nutr. 2003, 133, 1186.
• 7. Belury M.A.: Inhibition of carcinogenesis by conjugated linoleic; acid: Potential mechanisms of action. J. Nutr. 2002, 132, 2995.
• 8. Chen Z.Y., Pelletier G., Hollywood R. et al.: Trans fatty acid isomers in Canadian human milk. Lipids 1995, 30, 15.
• 9. Codex Alimentarius Commission. CCNFSDU. Discussion paper on Definition for Transj Fatty Acids. Joint FAO/WHO Food Standards Programme Codex Committee on Nutrition) and Foods for Special Dietary Uses. Twenty-sixth Session. 2004.
• 10. Corl B.A., Baumgard L.H., Griinari J.M. et al.: Trans-1 ,cis-9 CLA is synthesized endogenously by delta(9)- desaturase in dairy cows. Lipids 2002, 37, 68.
• 11. Craig-Schmidt M.C.: World wide consumption of trans fatty acids. In: Trans Fatty | Acids in Human Nutrition. Sebedio J.L., Christie W.W. (eds.) The Oily Press, Dundee, Scotland, 1998, 59.
• 12. Ens J.G., Ma D.W., Cole K.S. et al.: (2001). An assessment of c9,tll linoleic acid intake in a small group of young Canadians. Nutr. Res. 2001, 21, 955.
• 13. Food and Drug Administration. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Fed. Regist. 2003, 68, 41434. [Doc. electr. http://www.cfsan.fda.gov/~acrobat/fr03711a.pdf].
• 14. Fremann D., Linseisen J., Wolfram G.:l Dietary conjugated linoleic acid (CLA) intake assessment and possible biomarkers of CLAj intake in young women. Public Health Nutr. 2002, 5, 73.
• 15. Friesen R., Innis S.M.: Trans fatty acids in human milk in Canada declined with the introduction of trans fat food labeling. J. Nutr. 2006, 136; 2558.
• 16. Fritsche J., Fritsche S., Solomon M.B. et al.: Quantitative J determination of conjugated linoleic acid isomers in beef fat. Eur. J. Lipid Sei. Technol. 2000, 102, 667.
• 17. Fritsche J., Steinhart H.: Contents of trans fatty acids (TFA) in German foods and estimation of daily intake. Fett-Lipid 1997, 99, 314.
• 18. Griinari J.M., Corl B.A., Lacy] S.H. et al.: Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by A9-desaturase. J. Nutr. 2000, 130, 2285.
• 19. Gläser K.R., Scheeder M.R.L., Wenk C.: Dietary C18:l trans fatty acids increase conjugated linoleic acid in adiposse tissue of pigs. Eur. J. Lipid Sei. Technol. 2000, 102, 684.
• 20. Health Canada (2005). [Updated: 2006 June19]. [Doc. electr. http://www.hc-sc.gc.ca/fn-an/nutrition/gras-trans-fats/tf-ge/tf-gt_app4_e.html].
• 21. Hodgson J.M., Wahlqvist M.L., Boxall J.A. et al.: Platelet trans fatty acids in relation to angiographically assessed coronary artery disease. Atherosclerosis 1996, 120, 147.
• 22. Holman R.T., Mahfouz M.M.: Cis and frans-octadecenoic acids as precursors of polyunsaturated acids. Prog. Lip. Res. 1981, 20, 151.
• 23. Ip C., Dong Y., Thompson H.J. et al.: Control of rat mammary epithelium proliferation by conjugated linoleic acid. Nutr. Cancer 2001, 39, 233.
• 24. Jahreis G., Fritsche J., Kraft J.: Species dependent, seasonal, and dietary variation of conjugated linoleic acid in milk. In: Advances in conjugated linoleic acid research. Yurawecz M.P., Mossoba M.M., Kramer J.K.G., Pariza M.W., Nelson G.J. (eds.) AOCS Press, Champaign, Illinois, 1999, Vol. 1, 215.
• 25. Jaudszus A., Foerster M., Kroegel C. et al.: Cis-9,Trans-] 1-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: Comparison to Trans-10,Cis-12-CLA and to linoleic acid. Biochim. Biophys. Acta 2005, 1737, 111.
• 26. Katz A.M.: Trans-fatty acids and sudden cardiac death. Circulation 2002, 105, 669.
• 27. Kelley D.S., Simon V.A, Taylor P.C. et al.: Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function. Lipids 2001, 36, 669.
• 28. Koletzko B., Thiel I, Abiodun P.O.: Fatty acid composition of mature human milk in Nigeria. Z. Ernahrungswiss. 1991, 30, 289.
• 29. Kraft J., Hanske L., Moeckel P. et al.: The conversion efficiency of trans-11 and trans-12 18:1 by Delta9-desaturation differs in rats. J. Nutr. 2006, 136, 1209.
• 30. Kraft J., Kuhnt K, Kramer J.K.G. et al.: Trans-18:1 profile in food and the potential physiological relevance. Abstract. 4th Eur. Fed. Lipid Congress, Madrid, Spain, 2006, 17.
• 31. Kuhnt K., Kraft J., Moeckel P. et al.: Trans-ll-18:l is effectively Δ9-desaturated compared with trans-12-18:l in humans. Br. J. Nutr. 2006, 95, 752.
• 32. Kuhnt K, Wagner A., Kraft J. et al.: Dietary supplementation with trans11 C18:l and trans12 C18:l and oxidative stress in humans. Am. J. Clin. Nutr. 2006, 84, 981.
• 33. Kuhnt K, Kraft J., Vogelsang H. et al.: Dietary supplementation with trans-11- and trans-12-18 : 1 increases cis-9, frans-11-conjugated linoleic acid in human immune cells, but without effects on biomarkers of immune function and inflammation. Br. J. Nutr. 2007, 97, 1196.
• 34. Lee K.W., Lee HJ., Cho H.Y. et al.: Role of the conjugated linoleic acid in the prevention of cancer. Crit. Rev. Food Sei. Nutr. 2005, 45, 135.
• 35. Lemaitre R.N., King I.B., Mozaffarian D. et al.: Plasma phospholipid frans-fatty acids and fatal ischemic heart disease in older adults. The Cardiovascular Health Study. Circulation 2006, 114, 209.
• 36. Libby P.: Inflammation in atherosclerosis. Nature 2002, 420, 868.
• 37. Loor J.J., Lin X., Herbein J.H.: Dietary frans-vaccenic acid (trans-11-18:1) increases concentration of cis9,trans 11 - conjugated linoleic acid (rumenic acid) in tissues of lactating mice and suckling pups. Reprod. Nutr. Dev. 2002, 42, 85.
• 38. Lopez-Garcia E., Schulze M.B., Meigs J.B. et al.: Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005, 135, 562.
• 39. Mensink R.P., Zock P.L., Kester A.D.M. et al.: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146.
• 40. Mosley E.E., Shafii B., Moate P.J. et al.: cis-9, trans-11 conjugated linoleic acid is synthesized directly from vaccenic acid in lactating dairy cattle. J. Nutr. 2006, 136, 570.
• 41. Mosley E.E., Wright A.L., McGuire M.K. et al.: Trans fatty acids in milk produced by women in the United States. Am. J. Clin. Nutr. 2005, 82, 1292.
• 42. Mozaffarian D., Katan M.B., Ascherio A. et al.: Medical progress - Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601.
• 43. Mozaffarian D., Pischon T., Hankinson S.E. et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 2004, 79, 606.
• 44. Mozaffarian D., Rimm E.B., King I.B. et al.: trans Fatty acids and systemic inflammation in heart failure. Am. J. Clin. Nutr. 2004, 80, 1521.
• 45. Ntambi J.M.: Regulation of stearoyl-CoA desaturase expression. Lipids 2004, 39, 1061.
• 46. Oh K., Hu F.B., Manson J.E. et al.: Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am. J. Epidemiol. 2005, 161, 672.
• 47. O'Shea M., Bassaganya-Riera J., Mohede I.C.M.: Modulatory properties of conjugated linoleic acid. Am. J. Clin. Nutr. 2004, 79, 1199S.
• 48. Parodi P.W.: Anti-cancer agents in milkfat. Austr. J. Dairy. Techn. 2003, 58, 114.
• 49. Poirier H., Shapiro J.S., Kim R.J. et al.: Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 2006, 55, 1634.
• 50. Precht D., Molkentin J.: C18:l, C18:2 and C18:3 trans and cis fatty acid isomers including conjugated cis-9, trans-11 linoleic acid (CLA) as well as total fat composition of German human milk lipids. Nahrung 1999,43, 233.
• 51. Precht D., Molkentin J., Destaillats F. et al.: Comparative studies on individual isomeric 18:1 acids in cow, goat, and ewe milk fats by low-temperature high-resolution capillary gas-liquid chromatography. Lipids 2001, 36, 827.
• 52. Ringseis R., Mueller A., Herter C. et al.: CLA isomers inhibit TNF alpha-induced eicosanoid release from human vascular smooth muscle cells via a PPAR-gamma ligand-like action. Biochim. Biophys. Acta 2006, 1760, 290.
• 53. Risérus U., Basu S., Jovinge S. et al.: Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein - A potential link to fatty acid-induced insulin resistance. Circulation 2002, 106, 1925.
• 54. Risérus U., Berglund L., Vessby B.: Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 1129.
• 55. Saravanan N, Haseeb A., Ehtesham N.Z. et al.: Differential effects of dietary saturated and trans-ialty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur. J. Endocrinol. 2005, 15, 159.
• 56. Smedman A., Basu S., Jovinge S. et al.: Conjugated linoleic acid increased C-reactive protein in human subjects. Br. J. Nutr. 2005, 94, 791.
• 57. Smedman A., Vessby B.: Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids 2001, 36, 773.
• 58. Song H.J., Sneddon A.A., Heys S.D. et al.: Induction of apoptosis and inhibition of NF-kappa B activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate 2006, 66, 1 839.
• 59. Stachowska E., Dolegowska B., Olszewska M. et al.: Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase. Nutrition 2004, 20, 570.
• 60. Steinhart H., Pfalzgraf A.: Intake of trans isomeric fatty acids - an update for the federal-republic-of-Germany. Z. Ernaehrungswiss. 1992, 31, 196.
• 61. Steinhart H., Rickert R., Winkler K.: Trans fatty acids (TFA): Analysis, occurrence, intake and clinical relevance. Eur. J. Med. Res. 2003, 8, 358.
• 62. Stender S„ Dyerberg J.: Influence of trans fatty acids on health. Ann. Nutr. Metab. 2004, 48, 61.
• 63. Sundram K., Ismail A., Hayes K.C. et al.: Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J. Nutr. 1997, 127,. S514.
• 64. Tricon S., Burdge G.C., Jones E.L. et al.: Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am. J. Clin. Nutr. 2006, 83, 744.
• 65. Turpeinen A.M., Mutanen M.A.A., Salminen I. et al.: Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am. J. Clin. Nutr. 2002, 76, 504.
• 66. van de Vijver L.P.L., Kardinaal A.F.M., Couet C. et al Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur. J. Clin. Nutr. 2000, 54, 126.
• 67. Voorrips L.E., Brants H.A.M., Kardinaal A.F.M. et al.: Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am. J. Clin. Nutr. 2002, 76, 873.
• 68. Wahle K.W.J., Heys S.D., Rotondo D.: Conjugated linoleic acids: are they beneficial or detrimental to health? Progress in Lipid Research 2004, 43, 553.
• 69. Wang Y.W., Jones P.J.H.: Dietary conjugated linoleic acid and body composition. Am. J. Clin. Nutr. 2004, 79, 1153S.